Skip to main content
. 2024 Feb 12;30(3):730–739. doi: 10.1038/s41591-023-02791-w

Fig. 5. Overall survival by RAS/BRAF and MSS status.

Fig. 5

ac, Kaplan–Meier estimates of OS in patients with left-sided primary tumors (a), patients with right-sided primary tumors (b) and the overall population (all ctDNA-evaluable patients) (c). The forest plots below each Kaplan–Meier plot show HR ± 95% CI. A Cox proportional hazard model without stratification factors was used to calculate HRs for group comparisons and P values for the interaction between negative hyperselection status and treatment group. Statistical tests were two-sided without adjustment for multiple comparisons.